6730.TWO · LAGIS
Taiwan · RS rating 26 · As of 2026-10-08
| Price | 33.00 TWD |
|---|---|
| 1-day change | +3.5% |
| RS rating (overall / 1M / 3M / 12M) | 26 / 62 / 22 / 13 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 29 / 20 / 12 |
| Industry group (rank) | Medical-Biomed/Biotech (53) |
| EPS growth Q/Q | +4.7% |
| Sales growth Q/Q | +11.3% |
| Distance from 52-week high | +34.3% |
| Market cap (USD) | $36.3M |